The Department for Transport has announced that it is extending the Blue Badge scheme so that more people with ‘invisible’ health problems, such as autism and mental health problems, can now apply.

Research presented at Alzheimer’s Association International Conference (AAIC) has found that 10 minutes of social interaction a day helps improve wellbeing for people with dementia in care homes.

Research presented at Alzheimer’s Association International Conference (AAIC) today has found that the cholesterol control drug, gemfibrozil, reduces levels of amyloid and brain inflammation in mice.

Research presented at Alzheimer’s Association International Conference (AAIC) today shows that a genetic variant of the PLCG2, a gene previously associated with risk of Alzheimer’s Disease, may reduce the risk of developing some dementias and healthy ageing.

The Falkland Islands have today been shown to be a compassionate, sensible and progressive society which cares deeply about its terminally ill citizens and rightly feels that they deserve better, says Dignity in Dying.

Sajid Javid has announced that medical cannabis will be available on prescription, following the high-profile case of Billy Caldwell.

Research presented at Alzheimer’s Association International Conference (AAIC) has found evidence in support of the “amyloid hypothesis”. BAN2401 drug treatment was found to reduce amyloid in the brain, a protein associated with Alzheimer’s disease.

Concerns have been raised over the low number of people with diabetes who have been prescribed new “game-changing” technology following the results of a nationwide investigation.

A phase 1 trial reported in Nature Communications today has found that blood‒brain barrier  (BBB) can be non-invasively and reversibly opened in five patients with Alzheimer’s disease. The early results suggest that the procedure is safe, but it is unclear from the research how effective this is.

The public overwhelmingly supports letting nurses from the European Union work in the UK after Brexit, a new poll has found.

The 'disproportionally high' demand for BAME organ donations coupled with the 'extremely low' supply has created a serious health crisis, writes Eleanor Smith MP. 

Research presented at Alzheimer’s Association International Conference (AAIC) today shows that a study of the immunotherapy treatment Crenezumab has found it can reduce levels of the protein amyloid, associated with dementia.

Research presented at Alzheimer’s Association International Conference (AAIC) today shows that a potential new drug to treat Alzheimer’s disease, Lanabecestat, has failed a phase 2/3 trial. Pharmaceutical giants Eli Lilly and AstraZeneca have announced that they are ending two phase 3 trials into the drug.

Research presented at Alzheimer’s Association International Conference (AAIC) today shows that air pollution could have an effect on cognitive ageing. Results showed that exposure to air pollution in early life was linked to cognitive ageing, but it had little effect in later life.

Research from the Systolic Blood Pressure Intervention Trial (SPRINT) presented at Alzheimer’s Association International Conference (AAIC) today shows that treatment to lower blood pressure can reduce Mild Cognitive Impairment (MCI).

Diabetes care in nursing homes still remains “fragmented” and urgent steps need to be taken to restore the “health and dignity” of older people, leading experts have said.

The perception of former soldiers as being damaged by their experience in the army is wrong and could put off those who need help from getting it, MPs have said.

Research presented in Chicago today at Alzheimer’s Association International Conference (AAIC) reveals differences in diagnosis rates between black and white men in the UK. 

By allowing access to technology today, the NHS can create a better tomorrow for people with Type 1 diabetes, says George Howarth MP. 

The figures released today by the Office for National Statistics show there has been a 7.4% increase in deaths from all forms of dementia – with a 5.3% increase in deaths from vascular and unspecified dementia, and a 13.9% increase in deaths from Alzheimer‘s disease.

The clinical judgement of a registered medical practitioner, rather than the six month time limit, should define what is considered a "terminal illness", says Madeleine Moon MP.

The Government’s official spending watchdog has become the latest body to reject ministers’ claims that a “Brexit dividend” will help fund a huge funding boost for the NHS.

Government Whip and former Transport Minister Paul Maynard MP writes about cerebral palsy which he has had since birth. As a new guide for MPs and their staff is published he writes: "Let’s make sure we play our part in helping every child in the country to gain consistent access to high-quality services, enabling them to achieve their full potential in their future later lives".  

We must improve perinatal mental health for the “hidden half” of women with postnatal ill health, write Andrew Selous and Dr Paul Williams